OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

Inclusion Criteria: * Has a positive history of ocular allergies and a positive skin test reaction to a perennial allergen and a seasonal allergen * Has a positive bilateral CAC reaction to a perennial allergen within minutes of instillation Exclusion Criteria: * History of ocular surgical intervention within the past 3 months * Presence of an active ocular infection or positive history of an ocular herpetic infection at any visit * Use any of the following disallowed medications during the period indicated